• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development

Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development

Hardcover

Medical ReferenceChemistry

ISBN10: 1118537335
ISBN13: 9781118537336
Publisher: Wiley
Published: Jul 31 2018
Pages: 576
Weight: 1.98
Height: 1.30 Width: 6.10 Depth: 9.10
Language: English

A comprehensive review of contemporary antisense oligonucleotides drugs and therapeutic principles, methods, applications, and research

Oligonucleotide-based drugs, in particular antisense oligonucleotides, are part of a growing number of pharmaceutical and biotech programs progressing to treat a wide range of indications including cancer, cardiovascular, neurodegenerative, neuromuscular, and respiratory diseases, as well as other severe and rare diseases. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide covering all key aspects of this increasingly popular area of pharmacology and biotech and pharma research, from the basic science behind antisense oligonucleotides chemistry, toxicology, manufacturing, to safety assessments, the design of therapeutic protocols, to clinical experience.

Also in

Medical Reference